Percutaneous nephrostomy catheter use in gynecologic malignancy: M. D. Anderson Hospital experience

B. Stephens Dudley; David M. Gershenson; John J. Kavanagh; Larry J. Copeland; Cesar H. Carrasco; Felix N. Rutledge

doi:10.1016/0090-8258(86)90303-3

Percutaneous nephrostomy catheter use in gynecologic malignancy: M. D. Anderson Hospital experience

B. Stephens Dudley, David M. Gershenson, John J. Kavanagh, Larry J. Copeland, Cesar H. Carrasco, Felix N. Rutledge

Gynecological Oncology & Reproductive Medicine

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

The clinical courses of 30 patients with 41 nephrostomy catheters were followed. Duration of drainage ranged from 2 days to 15 months with a mean of 3.7 months. The most common complications were hemorrhage (28%), infection (70%), and blockage of catheter (65%). No deaths occurred as a result of these complications. Renal function recovered in 14 of 20 patients (70%) who presented with elevated creatinine values. Twenty-six of 28 patients with malignant obstruction were able to receive further therapy. The only long-term survivors presented with primary advanced cervical cancer.

Original language	English (US)
Pages (from-to)	273-278
Number of pages	6
Journal	Gynecologic oncology
Volume	24
Issue number	3
DOIs	https://doi.org/10.1016/0090-8258(86)90303-3
State	Published - Jul 1986

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/0090-8258(86)90303-3

Cite this

@article{eb14548ec43642508602e969f5207e40,

title = "Percutaneous nephrostomy catheter use in gynecologic malignancy: M. D. Anderson Hospital experience",

abstract = "The clinical courses of 30 patients with 41 nephrostomy catheters were followed. Duration of drainage ranged from 2 days to 15 months with a mean of 3.7 months. The most common complications were hemorrhage (28%), infection (70%), and blockage of catheter (65%). No deaths occurred as a result of these complications. Renal function recovered in 14 of 20 patients (70%) who presented with elevated creatinine values. Twenty-six of 28 patients with malignant obstruction were able to receive further therapy. The only long-term survivors presented with primary advanced cervical cancer.",

author = "Dudley, {B. Stephens} and Gershenson, {David M.} and Kavanagh, {John J.} and Copeland, {Larry J.} and Carrasco, {Cesar H.} and Rutledge, {Felix N.}",

year = "1986",

month = jul,

doi = "10.1016/0090-8258(86)90303-3",

language = "English (US)",

volume = "24",

pages = "273--278",

journal = "Gynecologic oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "3",

}

TY - JOUR

T1 - Percutaneous nephrostomy catheter use in gynecologic malignancy

T2 - M. D. Anderson Hospital experience

AU - Dudley, B. Stephens

AU - Gershenson, David M.

AU - Kavanagh, John J.

AU - Copeland, Larry J.

AU - Carrasco, Cesar H.

AU - Rutledge, Felix N.

PY - 1986/7

Y1 - 1986/7

N2 - The clinical courses of 30 patients with 41 nephrostomy catheters were followed. Duration of drainage ranged from 2 days to 15 months with a mean of 3.7 months. The most common complications were hemorrhage (28%), infection (70%), and blockage of catheter (65%). No deaths occurred as a result of these complications. Renal function recovered in 14 of 20 patients (70%) who presented with elevated creatinine values. Twenty-six of 28 patients with malignant obstruction were able to receive further therapy. The only long-term survivors presented with primary advanced cervical cancer.

AB - The clinical courses of 30 patients with 41 nephrostomy catheters were followed. Duration of drainage ranged from 2 days to 15 months with a mean of 3.7 months. The most common complications were hemorrhage (28%), infection (70%), and blockage of catheter (65%). No deaths occurred as a result of these complications. Renal function recovered in 14 of 20 patients (70%) who presented with elevated creatinine values. Twenty-six of 28 patients with malignant obstruction were able to receive further therapy. The only long-term survivors presented with primary advanced cervical cancer.

UR - http://www.scopus.com/inward/record.url?scp=0022544197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022544197&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(86)90303-3

DO - 10.1016/0090-8258(86)90303-3

M3 - Article

C2 - 3721300

AN - SCOPUS:0022544197

SN - 0090-8258

VL - 24

SP - 273

EP - 278

JO - Gynecologic oncology

JF - Gynecologic oncology

IS - 3

ER -

Percutaneous nephrostomy catheter use in gynecologic malignancy: M. D. Anderson Hospital experience

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this